McKesson Corporation logo
McKesson Corporation (MCK)
Compare

MCK Financials

SEC Filings

MCK Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
403.430B96.295B106.158B103.150B97.827B90.823B95.294B93.651B79.283B
Cost of Goods Sold
388.880B92.251B102.473B99.608B94.548B87.903B92.074B90.505B76.327B
14.550B4.044B3.685B3.542B3.279B2.920B3.220B3.146B2.956B
4.2%4.2%3.5%3.4%3.4%3.2%3.4%3.4%3.7%
Total Operating Expenses
8.179B1.796B2.066B2.074B2.243B1.884B1.933B2.401B1.895B
0.000.000.000.000.000.000.000.000.00
4.036B1.796B-2.030B2.074B2.196B1.884B1.933B2.401B1.895B
6.371B2.248B1.619B1.468B1.036B1.036B1.287B745.000M1.061B
2.3%2.3%1.5%1.4%1.1%1.1%1.4%0.8%1.3%
6.201B2.125B1.630B1.395B1.051B1.515B1.226B534.000M1.084B
Interest Income
125.000M-61.000M63.000M74.000M49.000M45.000M67.000M78.000M66.000M
Other Income/Expense
-170.000M-123.000M11.000M-73.000M15.000M479.000M-61.000M-211.000M23.000M
4.762B1.682B1.186B1.110B784.000M1.260B879.000M241.000M915.000M
1.102B270.000M380.000M232.000M220.000M209.000M298.000M247.000M124.000M
1.7%1.7%1.1%1.1%0.8%1.4%0.9%0.3%1.2%
7.017B2.260B1.843B1.657B1.257B1.711B1.446B775.000M1.319B
2.3%2.3%1.7%1.6%1.3%1.9%1.5%0.8%1.7%
729.000M196.000M188.000M188.000M157.000M151.000M153.000M163.000M169.000M
38.6413.789.638.956.2810.066.981.877.05
38.4713.719.598.926.2510.016.941.867.00
122.100M122.100M123.200M124.000M124.900M125.200M126.000M128.700M129.800M
122.700M122.700M123.700M124.400M125.500M125.900M126.600M129.300M130.700M

MCK Annual Income Statement (USD)

Annual Report
03/31/2026
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
03/31/2020
03/31/2019
403.430B359.051B308.951B276.711B263.966B238.228B231.051B214.319B
Cost of Goods Sold
388.880B346.566B296.749B264.842B251.317B226.646B219.651B203.557B
14.550B12.485B12.202B11.869B12.649B11.582B11.400B10.762B
3.6%3.5%3.9%4.3%4.8%4.9%4.9%5.0%
Total Operating Expenses
8.096B8.113B8.275B7.416B9.926B8.072B8.388B7.684B
103.000M91.000M77.000M89.000M70.000M74.000M96.000M71.000M
-8.096B8.022B8.198B7.327B9.856B7.998B8.292B7.613B
6.454B4.372B3.927B4.453B2.723B3.510B3.012B3.078B
1.6%1.2%1.3%1.6%1.0%1.5%1.3%1.4%
6.201B4.359B3.789B4.630B1.928B-5.034B1.144B610.000M
Interest Income
179.000M173.000M118.000M107.000M10.000M12.000M49.000M39.000M
247.000M256.000M243.000M248.000M178.000M217.000M249.000M264.000M
Other Income/Expense
-253.000M-13.000M-138.000M177.000M-795.000M-8.544B-1.868B-2.468B
4.762B3.295B3.002B3.560B1.114B-4.539B900.000M34.000M
1.102B878.000M629.000M905.000M636.000M-695.000M18.000M356.000M
1.2%0.9%1.0%1.3%0.4%-1.9%0.4%0.0%
7.177B5.251B4.667B5.735B3.107B-3.596B2.315B1.823B
1.8%1.5%1.5%2.1%1.2%-1.5%1.0%0.9%
729.000M636.000M635.000M857.000M1.001B1.221B922.000M949.000M
38.5525.8622.5425.237.31-27.024.970.17
38.3825.7222.3925.047.23-27.024.950.17
123.600M127.400M133.200M141.100M152.300M160.600M181.000M196.300M
124.100M128.100M134.100M142.200M154.100M160.600M182.000M197.300M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX
44,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Brian S. Tyler